news
Understanding EGFR-Positive Lung Cancer: What the Mutation Means for Treatment
EGFR-positive lung cancer is driven by specific gene mutations. Learn how targeted therapies like osimertinib work, who is tested, and what to expect from treatment.
Molecular Profiling on Detroit Bureau.
Every article on Detroit Bureau about Molecular Profiling — 2 stories covering it, newest first.
EGFR-positive lung cancer is driven by specific gene mutations. Learn how targeted therapies like osimertinib work, who is tested, and what to expect from treatment.
Explore the roles of EGFR and ALK biomarkers in non-small cell lung cancer, how they guide targeted therapy decisions, and what patients should know about testing and resistance.